Paloma Partners Management CO Moderna, Inc. Transaction History

Paloma Partners Management CO

$3.28 Billion
Q2 2024

A detailed history of Paloma Partners Management CO transactions in Moderna, Inc. stock. As of the latest transaction made, Paloma Partners Management CO holds 5,800 shares of MRNA stock, worth $381,350. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,800

Previous 3,094 87.46%

Holding current value

$381,350

Previous $329,000 109.12%

% of portfolio

0.02%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $289,764 - $477,004	2,863 Added 92.53%	5,957 $707,000
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $264,134 - $357,171	3,094 New	3,094 $329,000
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $7,423 - $9,748	77 New	77 $7,000
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $280,534 - $461,371	2,376 Added 144.17%	4,024 $476,000
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $455,869 - $687,288	-3,892 Reduced 70.25%	1,648 $235,000
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $137,462 - $255,499	1,087 Added 24.41%	5,540 $954,000
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $1.01 Million - $1.64 Million	4,453 New	4,453 $1.13 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $9,985 - $21,801	-45 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $5,845 - $10,574	45 New	45 $11,000
Q4 2020 Feb 16, 2021	SELL	$65.74 - $169.86 $197,219 - $509,580	-3,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $3.1 Million - $5.41 Million	-57,072 Reduced 95.01%	3,000 $212,000
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $1.78 Million - $4.81 Million	60,072 New	60,072 $3.86 Million
Q1 2020 May 15, 2020	SELL	$17.78 - $31.58 $308,909 - $548,670	-17,374 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$13.93 - $21.28 $242,019 - $369,718	17,374 New	17,374 $340,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Account

Paloma Partners Management CO Moderna, Inc. Transaction History